View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsFutureCoreLtd 과거 순이익 실적과거 기준 점검 0/6FutureCoreLtd은 연평균 0.5%의 비율로 수입이 증가해 온 반면, Electronic 산업은 연평균 6.5%의 비율로 증가했습니다. 매출은 연평균 0.4%의 비율로 증가했습니다.핵심 정보0.54%순이익 성장률4.86%주당순이익(EPS) 성장률Electronic 산업 성장률21.63%매출 성장률0.40%자기자본이익률-28.89%순이익률-12.22%최근 순이익 업데이트30 Jun 2025최근 과거 실적 업데이트Reported Earnings • Mar 15Full year 2023 earnings released: ₩43.00 loss per share (vs ₩91.00 loss in FY 2022)Full year 2023 results: ₩43.00 loss per share (improved from ₩91.00 loss in FY 2022). Revenue: ₩48.3b (down 5.0% from FY 2022). Net loss: ₩7.66b (loss narrowed 52% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 57% per year, which means it is performing significantly worse than earnings.모든 업데이트 보기Recent updates분석 기사 • Nov 24FutureCoreLtd (KOSDAQ:151910) Shareholders Will Want The ROCE Trajectory To ContinueFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Board Change • Nov 18High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. Independent Outside Director SeungKwan Choi is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공시 • Jul 17An undisclosed buyer agreed to acquire 99.79% stake in GVBT Union No. 4 from FutureCore Co.,Ltd. (KOSDAQ:A151910) for KRW 3.6 billion.An undisclosed buyer agreed to acquire 99.79% stake in GVBT Union No. 4 from FutureCore Co.,Ltd. (KOSDAQ:A151910) for KRW 3.6 billion on April 17, 2025. A cash consideration of KRW 3.6 billion will be paid by the buyer. The expected completion of the transaction is September 16, 2025.공시 • Mar 18FutureCore Co.,Ltd., Annual General Meeting, Mar 31, 2025FutureCore Co.,Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: auditorium, 13, sinwon-ro 250beon-gil, yeongtong-gu, gyeonggi-do, suwon South KoreaNew Risk • Mar 20New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 7.3% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (6.3% increase in shares outstanding). Market cap is less than US$100m (₩120.6b market cap, or US$90.2m).Reported Earnings • Mar 15Full year 2023 earnings released: ₩43.00 loss per share (vs ₩91.00 loss in FY 2022)Full year 2023 results: ₩43.00 loss per share (improved from ₩91.00 loss in FY 2022). Revenue: ₩48.3b (down 5.0% from FY 2022). Net loss: ₩7.66b (loss narrowed 52% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 57% per year, which means it is performing significantly worse than earnings.분석 기사 • Feb 27Subdued Growth No Barrier To SBW Life Sciences Co.,Ltd. (KOSDAQ:151910) With Shares Advancing 51%SBW Life Sciences Co.,Ltd. ( KOSDAQ:151910 ) shareholders would be excited to see that the share price has had a great...New Risk • Feb 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 7.0% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩77.6b market cap, or US$58.3m).New Risk • Dec 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 7.0% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₩76.2b market cap, or US$57.9m).New Risk • Jun 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 7.6% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₩93.3b market cap, or US$71.3m).Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Outside Director Hyuk-Jae Lee was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • Jul 19SBW Life Sciences Co.,Ltd. announced that it has received KRW 17.6 billion in funding from IokCompany Co., Ltd.On July 18, 2022, SBW Life Sciences Co.,Ltd. closed the transaction.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Outside Director Hyuk-Jae Lee was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • Apr 07Nanos Co., Ltd. announced that it has received KRW 30 billion in fundingOn April 5, 2021, Nanos Co., Ltd. (KOSDAQ:A151910) closed the transaction.Is New 90 Day High Low • Feb 20New 90-day high: ₩7,070The company is up 105% from its price of ₩3,445 on 20 November 2020. The South Korean market is up 19% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 39% over the same period.공시 • Feb 10Nanos Co., Ltd. announced that it expects to receive KRW 30 billion in fundingNanos Co., Ltd. (KOSDAQ:A151910) announced a private placement of round 5 Unregistered coupon nonguaranteed private convertible bond for gross proceeds of KRW 30,000,000,000 on February 9, 2021. The transaction will include participation from DB W Fund 1. The bond carry 4% coupon nominal rate, 6% maturity rate and will mature on April 5, 2026. The bonds can be 100% converted into 7,447,864 common shares at a conversion price of KRW 4,028 per share for 4.77% stakes. The conversion period is from April 5, 2022 to March 5, 2026. The transaction has been approved by the board of directors of the company. The securities issued in the transaction are subject to one year lock up period. The subscription date is February 15, 2021 and the payment date is April 5, 2021.Is New 90 Day High Low • Feb 03New 90-day high: ₩4,150The company is up 21% from its price of ₩3,425 on 05 November 2020. The South Korean market is up 28% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 44% over the same period.Is New 90 Day High Low • Jan 17New 90-day high: ₩3,700The company is up 1.0% from its price of ₩3,675 on 19 October 2020. The South Korean market is up 30% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 44% over the same period.Is New 90 Day High Low • Dec 15New 90-day low: ₩3,300The company is down 20% from its price of ₩4,100 on 16 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 9.0% over the same period.Is New 90 Day High Low • Nov 11New 90-day low: ₩3,305The company is down 12% from its price of ₩3,740 on 13 August 2020. The South Korean market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 3.0% over the same period.Is New 90 Day High Low • Oct 22New 90-day low: ₩3,600The company is down 17% from its price of ₩4,360 on 24 July 2020. The South Korean market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 5.0% over the same period.공시 • Jul 17+ 1 more updateNanos Co., Ltd. announced that it expects to receive KRW 3 billion in funding from Mirae Industry CO.,LTDNanos Co., Ltd. (KOSDAQ:A151910) announced a private placement of round four non-guaranteed private equity convertible bonds for gross proceeds of KRW 3,000,000,000 on July 13, 2020. The transaction will include participation from Mirae Industry CO.,LTD for KRW 3,000,000,000. The bond carry 2 percent coupon nominal rate, 2% maturity rate and will mature on July 14, 2023. The bonds can be 100% converted into 813,890 common shares at a conversion price of KRW 3,686 per share. The conversion period is from July 14, 2021 to June 14, 2023. The transaction has been approved by the board of directors of the company. The subscription date is July 14, 2020 and the payment date is July 14, 2020.매출 및 비용 세부 내역FutureCoreLtd가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이KOSDAQ:A151910 매출, 비용 및 순이익 (KRW Millions)날짜매출순이익일반관리비연구개발비30 Jun 2561,661-7,5376,42726631 Mar 2559,520-6,8526,39626631 Dec 2460,039-7,9307,02526630 Sep 2457,822-9,0678,12312230 Jun 2455,054-9,7687,35311231 Mar 2451,077-10,0527,44717631 Dec 2348,310-7,6647,12724230 Sep 2345,609-9,3867,20639830 Jun 2345,205-7,1568,38139631 Mar 2349,146-15,6088,31738431 Dec 2250,852-15,9117,59036730 Sep 2252,585-32,9136,5871,00430 Jun 2253,707-33,0056,10399731 Mar 2253,133-27,3845,11199931 Dec 2151,482-27,5125,24499730 Sep 2150,668-3,1613,95919230 Jun 2151,268-6,6684,01117731 Mar 2147,061-4,6894,13316031 Dec 2056,967-1,7694,51116030 Sep 2060,984-4,2585,65418930 Jun 2063,145-4,1696,34422531 Mar 2068,289-7,8829,23728031 Dec 1952,623-16,2889,74627830 Sep 1958,245-14,09912,61523230 Jun 1958,152-16,8919,45121131 Mar 1959,030-14,3153,93221031 Dec 1861,102-13,3263,29228330 Sep 1848,725-19,80051528430 Jun 1843,037-19,2301,30926331 Mar 1836,442-19,5944,27423431 Dec 1735,770-20,1502,13321530 Sep 1731,503102,11910,13971530 Jun 1731,46197,86114,50468931 Mar 1735,48047,98121,45140431 Dec 1639,67531,90423,49552930 Sep 1620,940-183,83018,89193030 Jun 1673,130-174,64416,16061831 Mar 1672,565-118,6949,73794531 Dec 1590,935-96,08210,2521,14230 Sep 1560,6529,1497,83117330 Jun 1546,6789,0526,90317331 Mar 1582,8788,9597,07853431 Dec 1493,5814,3887,275675양질의 수익: A151910 은(는) 현재 수익성이 없습니다.이익 마진 증가: A151910는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: A151910는 수익성이 없지만 지난 5년 동안 연평균 0.5%의 속도로 손실을 줄였습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 A151910의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: A151910은 수익성이 없어 지난 해 수익 성장률을 Electronic 업계(-4.4%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: A151910는 현재 수익성이 없으므로 자본 수익률이 음수(-28.89%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YTech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2025/11/26 06:10종가2025/11/25 00:00수익2025/06/30연간 수익2024/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스FutureCore Co.,Ltd.는 3명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Jun-Ho ByunEugene Investment & Securities Co Ltd.JooYoung LeeShinhan Investment Corp.Hyung Wou ParkSK Securities Co., Ltd.
Reported Earnings • Mar 15Full year 2023 earnings released: ₩43.00 loss per share (vs ₩91.00 loss in FY 2022)Full year 2023 results: ₩43.00 loss per share (improved from ₩91.00 loss in FY 2022). Revenue: ₩48.3b (down 5.0% from FY 2022). Net loss: ₩7.66b (loss narrowed 52% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 57% per year, which means it is performing significantly worse than earnings.
분석 기사 • Nov 24FutureCoreLtd (KOSDAQ:151910) Shareholders Will Want The ROCE Trajectory To ContinueFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Board Change • Nov 18High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. Independent Outside Director SeungKwan Choi is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공시 • Jul 17An undisclosed buyer agreed to acquire 99.79% stake in GVBT Union No. 4 from FutureCore Co.,Ltd. (KOSDAQ:A151910) for KRW 3.6 billion.An undisclosed buyer agreed to acquire 99.79% stake in GVBT Union No. 4 from FutureCore Co.,Ltd. (KOSDAQ:A151910) for KRW 3.6 billion on April 17, 2025. A cash consideration of KRW 3.6 billion will be paid by the buyer. The expected completion of the transaction is September 16, 2025.
공시 • Mar 18FutureCore Co.,Ltd., Annual General Meeting, Mar 31, 2025FutureCore Co.,Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: auditorium, 13, sinwon-ro 250beon-gil, yeongtong-gu, gyeonggi-do, suwon South Korea
New Risk • Mar 20New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 7.3% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (6.3% increase in shares outstanding). Market cap is less than US$100m (₩120.6b market cap, or US$90.2m).
Reported Earnings • Mar 15Full year 2023 earnings released: ₩43.00 loss per share (vs ₩91.00 loss in FY 2022)Full year 2023 results: ₩43.00 loss per share (improved from ₩91.00 loss in FY 2022). Revenue: ₩48.3b (down 5.0% from FY 2022). Net loss: ₩7.66b (loss narrowed 52% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 57% per year, which means it is performing significantly worse than earnings.
분석 기사 • Feb 27Subdued Growth No Barrier To SBW Life Sciences Co.,Ltd. (KOSDAQ:151910) With Shares Advancing 51%SBW Life Sciences Co.,Ltd. ( KOSDAQ:151910 ) shareholders would be excited to see that the share price has had a great...
New Risk • Feb 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 7.0% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩77.6b market cap, or US$58.3m).
New Risk • Dec 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 7.0% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₩76.2b market cap, or US$57.9m).
New Risk • Jun 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 7.6% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₩93.3b market cap, or US$71.3m).
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Outside Director Hyuk-Jae Lee was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • Jul 19SBW Life Sciences Co.,Ltd. announced that it has received KRW 17.6 billion in funding from IokCompany Co., Ltd.On July 18, 2022, SBW Life Sciences Co.,Ltd. closed the transaction.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Outside Director Hyuk-Jae Lee was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • Apr 07Nanos Co., Ltd. announced that it has received KRW 30 billion in fundingOn April 5, 2021, Nanos Co., Ltd. (KOSDAQ:A151910) closed the transaction.
Is New 90 Day High Low • Feb 20New 90-day high: ₩7,070The company is up 105% from its price of ₩3,445 on 20 November 2020. The South Korean market is up 19% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 39% over the same period.
공시 • Feb 10Nanos Co., Ltd. announced that it expects to receive KRW 30 billion in fundingNanos Co., Ltd. (KOSDAQ:A151910) announced a private placement of round 5 Unregistered coupon nonguaranteed private convertible bond for gross proceeds of KRW 30,000,000,000 on February 9, 2021. The transaction will include participation from DB W Fund 1. The bond carry 4% coupon nominal rate, 6% maturity rate and will mature on April 5, 2026. The bonds can be 100% converted into 7,447,864 common shares at a conversion price of KRW 4,028 per share for 4.77% stakes. The conversion period is from April 5, 2022 to March 5, 2026. The transaction has been approved by the board of directors of the company. The securities issued in the transaction are subject to one year lock up period. The subscription date is February 15, 2021 and the payment date is April 5, 2021.
Is New 90 Day High Low • Feb 03New 90-day high: ₩4,150The company is up 21% from its price of ₩3,425 on 05 November 2020. The South Korean market is up 28% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 44% over the same period.
Is New 90 Day High Low • Jan 17New 90-day high: ₩3,700The company is up 1.0% from its price of ₩3,675 on 19 October 2020. The South Korean market is up 30% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 44% over the same period.
Is New 90 Day High Low • Dec 15New 90-day low: ₩3,300The company is down 20% from its price of ₩4,100 on 16 September 2020. The South Korean market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Nov 11New 90-day low: ₩3,305The company is down 12% from its price of ₩3,740 on 13 August 2020. The South Korean market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 3.0% over the same period.
Is New 90 Day High Low • Oct 22New 90-day low: ₩3,600The company is down 17% from its price of ₩4,360 on 24 July 2020. The South Korean market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 5.0% over the same period.
공시 • Jul 17+ 1 more updateNanos Co., Ltd. announced that it expects to receive KRW 3 billion in funding from Mirae Industry CO.,LTDNanos Co., Ltd. (KOSDAQ:A151910) announced a private placement of round four non-guaranteed private equity convertible bonds for gross proceeds of KRW 3,000,000,000 on July 13, 2020. The transaction will include participation from Mirae Industry CO.,LTD for KRW 3,000,000,000. The bond carry 2 percent coupon nominal rate, 2% maturity rate and will mature on July 14, 2023. The bonds can be 100% converted into 813,890 common shares at a conversion price of KRW 3,686 per share. The conversion period is from July 14, 2021 to June 14, 2023. The transaction has been approved by the board of directors of the company. The subscription date is July 14, 2020 and the payment date is July 14, 2020.